Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Hoth

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Annals of the New York Academy of Sciences|June 23, 1993
Issues in the development of a prophylactic HIV vaccineD F Hoth
Hospital Practice (Office Ed.)|September 25, 1992
Current status of HIV therapy: II. Opportunistic diseasesJ Feinberg, D F Hoth
Hospital Practice (Office Ed.)|March 25, 1991
Current status of HIV therapy: II. Opportunistic diseasesJ Feinberg, D F Hoth
Annals of Internal Medicine|April 1, 1992
Surrogate markers in AIDS: where are we? Where are we going?S W Lagakos, D F Hoth
Seminars in Oncology|December 1, 1976
Natural history and staging of colon cancerD F Hoth, P E Petrucci
Annals of Epidemiology|December 1, 1990
How can epidemiology assist in guiding interventions for the acquired immunodeficiency syndrome/human immunodeficiency virus?S H Vermund, D F Hoth
Hospital Practice (Office Ed.)|January 25, 1991
Current status of HIV therapy: I. Antiretroviral agentsD F Hoth, M W Myers
Science (New York, N.Y.)|July 22, 1988
Development and testing of AIDS vaccinesW C Koff, D F Hoth
Science (New York, N.Y.)|May 28, 1993
Present status and future prospects for HIV therapiesM I Johnston, D F Hoth
Cancer Treatment Reports|October 1, 1984
Anaphylactic reactions to diaziquoneJ G Posada, P J O'Dwyer, D F Hoth
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Annals of the New York Academy of Sciences|June 23, 1993
Issues in the development of a prophylactic HIV vaccineD F Hoth
Hospital Practice (Office Ed.)|September 25, 1992
Current status of HIV therapy: II. Opportunistic diseasesJ Feinberg, D F Hoth
Hospital Practice (Office Ed.)|March 25, 1991
Current status of HIV therapy: II. Opportunistic diseasesJ Feinberg, D F Hoth
Annals of Internal Medicine|April 1, 1992
Surrogate markers in AIDS: where are we? Where are we going?S W Lagakos, D F Hoth
Seminars in Oncology|December 1, 1976
Natural history and staging of colon cancerD F Hoth, P E Petrucci
Annals of Epidemiology|December 1, 1990
How can epidemiology assist in guiding interventions for the acquired immunodeficiency syndrome/human immunodeficiency virus?S H Vermund, D F Hoth
Hospital Practice (Office Ed.)|January 25, 1991
Current status of HIV therapy: I. Antiretroviral agentsD F Hoth, M W Myers
Science (New York, N.Y.)|July 22, 1988
Development and testing of AIDS vaccinesW C Koff, D F Hoth
Science (New York, N.Y.)|May 28, 1993
Present status and future prospects for HIV therapiesM I Johnston, D F Hoth
Cancer Treatment Reports|October 1, 1984
Anaphylactic reactions to diaziquoneJ G Posada, P J O'Dwyer, D F Hoth
Pageof 5